Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0096 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.2847 | 0.2847 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0096 | 1 | 1 |
Onchocerca volvulus | 0.0037 | 0.1947 | 0.5 | |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0055 | 0.4414 | 0.5 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0043 | 0.2847 | 0.2847 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1947 | 0.1947 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0061 | 0.5298 | 0.5298 |
Plasmodium falciparum | thioredoxin reductase | 0.0096 | 1 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0059 | 0.4939 | 0.4939 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0055 | 0.4414 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0055 | 0.4414 | 0.4414 |
Loa Loa (eye worm) | glutathione reductase | 0.0096 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0043 | 0.2847 | 0.2847 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0055 | 0.4414 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0096 | 1 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0096 | 1 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0055 | 0.4414 | 0.5 |
Brugia malayi | calpain family protein 1 | 0.0059 | 0.4939 | 0.4939 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0055 | 0.4414 | 0.5 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.5 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Plasmodium vivax | glutathione reductase, putative | 0.0096 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0096 | 1 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.004 | 0.2448 | 0.2448 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Toxoplasma gondii | thioredoxin reductase | 0.0096 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.404 | 0.404 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0096 | 1 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0055 | 0.4414 | 0.5 |
Leishmania major | trypanothione reductase | 0.0096 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Echinococcus granulosus | calpain A | 0.0061 | 0.5298 | 0.5298 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0061 | 0.5298 | 0.5298 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0096 | 1 | 1 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0055 | 0.4414 | 0.4414 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0055 | 0.4414 | 0.4414 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.4939 | 0.4939 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0055 | 0.4414 | 0.4414 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0055 | 0.4414 | 0.5 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0061 | 0.5298 | 0.5298 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0059 | 0.4939 | 0.4939 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0055 | 0.4414 | 0.5 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0061 | 0.5298 | 0.5298 |
Trypanosoma brucei | trypanothione reductase | 0.0096 | 1 | 1 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.004 | 0.2448 | 0.2448 |
Treponema pallidum | NADH oxidase | 0.0055 | 0.4414 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0096 | 1 | 1 |
Brugia malayi | calpain family protein 1 | 0.0059 | 0.4939 | 0.4939 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0055 | 0.4414 | 0.4414 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0055 | 0.4414 | 0.4414 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0055 | 0.4414 | 0.4414 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0055 | 0.4414 | 0.4414 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0055 | 0.4414 | 0.5 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0055 | 0.4414 | 0.4414 |
Echinococcus multilocularis | calpain A | 0.0061 | 0.5298 | 0.5298 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Reversal (functional) | = 0 % | Percent reversal of scopalamine-induced amnesia rat following 10 mg/kg i.p. | ChEMBL. | 8277504 |
Reversal (functional) | = 3 % | Percent reversal of scopalamine-induced amnesia rat following 1.0 mg/kg i.p. | ChEMBL. | 8277504 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.